LLY

997.51

-1.14%↓

JNJ

201.81

+0.01%↑

ABBV

223.39

-1.26%↓

UNH

323.88

-2.01%↓

AZN

91.08

+1%↑

LLY

997.51

-1.14%↓

JNJ

201.81

+0.01%↑

ABBV

223.39

-1.26%↓

UNH

323.88

-2.01%↓

AZN

91.08

+1%↑

LLY

997.51

-1.14%↓

JNJ

201.81

+0.01%↑

ABBV

223.39

-1.26%↓

UNH

323.88

-2.01%↓

AZN

91.08

+1%↑

LLY

997.51

-1.14%↓

JNJ

201.81

+0.01%↑

ABBV

223.39

-1.26%↓

UNH

323.88

-2.01%↓

AZN

91.08

+1%↑

LLY

997.51

-1.14%↓

JNJ

201.81

+0.01%↑

ABBV

223.39

-1.26%↓

UNH

323.88

-2.01%↓

AZN

91.08

+1%↑

Inicio・Lista de Acciones・Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc

Abierto

SectorSalud

8.76 10.61

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

7.87

Máximo

8.98

Métricas clave
By Trading Economics
Ingresos	11M -20M
Ventas	5.9M 40M
BPA	-0.19
Margen de beneficio	-49.569
Empleados	184
EBITDA	16M -19M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+199.87% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	153M 901M
Apertura anterior	-1.85
Cierre anterior	8.76

Noticias sobre sentimiento de mercado

By Acuity

50%

175 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

6.26 / 7.47 Soporte y Resistencia

Day One Biopharmaceuticals Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

7 dic 2025, 23:00 UTC

Adquisiciones, fusiones, absorciones

Brookfield, GIC Agree $4.5 Billion Deal for Australia's National Storage -- Update

5 dic 2025, 21:08 UTC

Adquisiciones, fusiones, absorciones

Meta Platforms Buys AI-Device Maker Limitless

5 dic 2025, 19:39 UTC

Principales Movimientos del Mercado

Parsons' FAA Bid Loss Clouds Outlook After Rocky Year for Contractors

5 dic 2025, 19:17 UTC

Adquisiciones, fusiones, absorciones

Constellation Energy Agrees to Divest Assets to Finalize Calpine Deal

7 dic 2025, 23:42 UTC

Charlas de Mercado

Nikkei May Rise on Weaker Yen -- Market Talk

7 dic 2025, 23:05 UTC

Charlas de Mercado

RBA Set to Remain 'Emphatically' On Hold, Westpac Says -- Market Talk

7 dic 2025, 22:18 UTC

Charlas de Mercado

RBA Set To Conclude Year With Hawkish Message -- Market Talk

6 dic 2025, 16:52 UTC

Adquisiciones, fusiones, absorciones

As Netflix Swoops In to Buy Warner Bros., We Revisit the Studio's Long, Twisted Journey -- Barrons.com

6 dic 2025, 10:30 UTC

Adquisiciones, fusiones, absorciones

Why Netflix Shareholders Aren't Thrilled to Acquire Warner Bros. -- Heard on the Street -- WSJ

6 dic 2025, 02:38 UTC

Adquisiciones, fusiones, absorciones

How a Netflix-Warner Deal Would Change Everything in Hollywood -- Again -- WSJ

5 dic 2025, 21:59 UTC

Adquisiciones, fusiones, absorciones

Netflix's Megadeal Will Need the Trump Administration's Blessing -- Update

5 dic 2025, 21:50 UTC

Charlas de Mercado

Ganancias

Financial Services Roundup: Market Talk

5 dic 2025, 21:50 UTC

Adquisiciones, fusiones, absorciones

The Netflix and Warner Bros. Deal Is Far From a Sure Thing -- Barrons.com

5 dic 2025, 21:36 UTC

Charlas de Mercado

Return of Shipping to Red Sea a Step Closer, Xeneta Says -- Market Talk

5 dic 2025, 21:35 UTC

Adquisiciones, fusiones, absorciones

The Netflix-Warner Bros. Deal Has a Wildcard. How Paramount Could Still Win. -- Barrons.com

5 dic 2025, 21:26 UTC

Adquisiciones, fusiones, absorciones

Warner Bros. Discovery and Netflix Enter Exclusive Deal Negotiations -- 7th Update

5 dic 2025, 21:12 UTC

Charlas de Mercado

Natural Gas Surge 9% This Week on Strong Flow of Exports -- Market Talk

5 dic 2025, 21:03 UTC

Charlas de Mercado

Ganancias

Bank of Montreal Logs Solid Quarter, Though Some Unease Remains -- Market Talk

5 dic 2025, 21:01 UTC

Charlas de Mercado

Oil Caps Positive Week on Geopolitical Turmoil -- Market Talk

5 dic 2025, 20:43 UTC

Adquisiciones, fusiones, absorciones

Limitless CEO Siroker: Will No Longer Sell Pendant to New Customers

5 dic 2025, 20:43 UTC

Adquisiciones, fusiones, absorciones

Limitless CEO Siroker: Existing Pendant Customers to Be Supported for at Least Another Year

5 dic 2025, 20:42 UTC

Adquisiciones, fusiones, absorciones

Limitless CEO Dan Siroker: Limitless Has Been Acquired by Meta >META

5 dic 2025, 20:01 UTC

Adquisiciones, fusiones, absorciones

Netflix Landed a Big Deal. Now it Could Have a Big Fight. -- WSJ

5 dic 2025, 19:44 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

5 dic 2025, 19:44 UTC

Charlas de Mercado

Canada Dollar Gains Nearly 1% on Jobs Data, Rate Outlook -- Market Talk

5 dic 2025, 19:39 UTC

Charlas de Mercado

Silver Climbs to a New Record High -- Market Talk

5 dic 2025, 19:31 UTC

Adquisiciones, fusiones, absorciones

Netflix Stock Falls. Wall Street Is Worried About Warner Deal's High Price and Debt. -- Barrons.com

5 dic 2025, 18:30 UTC

Charlas de Mercado

Canada Jobless Rate Can Fall More Before Labor Slack Disappears -- Market Talk

5 dic 2025, 18:28 UTC

Adquisiciones, fusiones, absorciones

Netflix Stock Falls. Wall Street Is Worried About Warner Deal's High Price and Debt. -- Barrons.com

5 dic 2025, 18:24 UTC

Adquisiciones, fusiones, absorciones

AMC and IMAX Stocks Drop. Roku Rises. How the Netflix-Warner Bros. Deal Could Shake Up Entertainment. -- Barrons.com

Comparación entre iguales

Cambio de precio

Day One Biopharmaceuticals Inc Esperado

Precio Objetivo

By TipRanks

199.87% repunte

Estimación a 12 meses

Media 23.75 USD 199.87%

Máximo 34 USD

Mínimo 16 USD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Day One Biopharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

9 ratings

Comprar

Mantener

Vender

De acuerdo con 9 analistas que ofrecen calificaciones bursátiles a para Day One Biopharmaceuticals Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

6.26 / 7.47Soporte y Resistencia

Recent bearish events outweigh bullish events.

All events are bullish.

All events are bearish.

Sentimiento

By Acuity

175 / 374 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.